These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36793435)

  • 1. Discovery of OICR12694: A Novel, Potent, Selective, and Orally Bioavailable BCL6 BTB Inhibitor.
    Mamai A; Chau AM; Wilson BJ; Watson ID; Joseph BB; Subramanian PR; Morshed MM; Morin JA; Prakesch MA; Lu T; Connolly P; Kuntz DA; Pomroy NC; Poda G; Nguyen K; Marcellus R; Strathdee G; Theriault B; Subramaniam R; Mohammed M; Abibi A; Chan M; Winston J; Kiyota T; Undzys E; Aman A; Austin N; Du Jardin M; Packman K; Phillippar U; Attar R; Edwards J; O'Meara J; Uehling DE; Al-Awar R; Privé GG; Isaac MB
    ACS Med Chem Lett; 2023 Feb; 14(2):199-210. PubMed ID: 36793435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of an Irreversible and Cell-Active BCL6 Inhibitor Selectively Targeting Cys53 Located at the Protein-Protein Interaction Interface.
    Sameshima T; Yamamoto T; Sano O; Sogabe S; Igaki S; Sakamoto K; Ida K; Gotou M; Imaeda Y; Sakamoto J; Miyahisa I
    Biochemistry; 2018 Feb; 57(8):1369-1379. PubMed ID: 29293322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An orally available small molecule BCL6 inhibitor effectively suppresses diffuse large B cell lymphoma cells growth in vitro and in vivo.
    Xing Y; Guo W; Wu M; Xie J; Huang D; Hu P; Zhou M; Zhang L; Zhang Q; Wang P; Wang X; Wang G; Wu H; Zhou C; Chen Y; Liu M; Yi Z; Sun Z
    Cancer Lett; 2022 Mar; 529():100-111. PubMed ID: 34990752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of Pyrazolo[1,5-a]pyrimidine B-Cell Lymphoma 6 (BCL6) Binders and Optimization to High Affinity Macrocyclic Inhibitors.
    McCoull W; Abrams RD; Anderson E; Blades K; Barton P; Box M; Burgess J; Byth K; Cao Q; Chuaqui C; Carbajo RJ; Cheung T; Code E; Ferguson AD; Fillery S; Fuller NO; Gangl E; Gao N; Grist M; Hargreaves D; Howard MR; Hu J; Kemmitt PD; Nelson JE; O'Connell N; Prince DB; Raubo P; Rawlins PB; Robb GR; Shi J; Waring MJ; Whittaker D; Wylot M; Zhu X
    J Med Chem; 2017 May; 60(10):4386-4402. PubMed ID: 28485934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis of Apt48 inhibition of the BCL6 BTB domain.
    Zacharchenko T; Kalverda AP; Wright SC
    Structure; 2022 Mar; 30(3):396-407.e3. PubMed ID: 34774129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic targeting of the BCL6 oncogene for diffuse large B-cell lymphomas.
    Parekh S; Privé G; Melnick A
    Leuk Lymphoma; 2008 May; 49(5):874-82. PubMed ID: 18452090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of an
    Harnden AC; Davis OA; Box GM; Hayes A; Johnson LD; Henley AT; de Haven Brandon AK; Valenti M; Cheung KJ; Brennan A; Huckvale R; Pierrat OA; Talbot R; Bright MD; Akpinar HA; Miller DSJ; Tarantino D; Gowan S; de Klerk S; McAndrew PC; Le Bihan YV; Meniconi M; Burke R; Kirkin V; van Montfort RLM; Raynaud FI; Rossanese OW; Bellenie BR; Hoelder S
    J Med Chem; 2023 Apr; 66(8):5892-5906. PubMed ID: 37026591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress toward B-Cell Lymphoma 6 BTB Domain Inhibitors for the Treatment of Diffuse Large B-Cell Lymphoma and Beyond.
    Ai Y; Hwang L; MacKerell AD; Melnick A; Xue F
    J Med Chem; 2021 Apr; 64(8):4333-4358. PubMed ID: 33844535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inducible knock-out of BCL6 in lymphoma cells results in tumor stasis.
    Schlager S; Salomon C; Olt S; Albrecht C; Ebert A; Bergner O; Wachter J; Trapani F; Gerlach D; Voss T; Traunbauer A; Jude J; Hinterndorfer M; Minnich M; Schweifer N; Blake SM; Zinzalla V; Drobits B; McConnell DB; Kraut N; Pearson M; Zuber J; Koegl M
    Oncotarget; 2020 Mar; 11(9):875-890. PubMed ID: 32180900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B-cell Lymphoma 6 Inhibitors: Current Advances and Prospects of Drug Development for Diffuse Large B-cell Lymphomas.
    Gu H; He J; Li Y; Mi D; Guan T; Guo W; Liu B; Chen Y
    J Med Chem; 2022 Dec; 65(23):15559-15583. PubMed ID: 36441945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted therapy of BCL6-dependent diffuse large B-cell lymphomas by heat-shock protein 90 inhibition.
    Briones J
    Expert Rev Hematol; 2010 Apr; 3(2):157-9. PubMed ID: 21083459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemically Induced Degradation of the Oncogenic Transcription Factor BCL6.
    Kerres N; Steurer S; Schlager S; Bader G; Berger H; Caligiuri M; Dank C; Engen JR; Ettmayer P; Fischerauer B; Flotzinger G; Gerlach D; Gerstberger T; Gmaschitz T; Greb P; Han B; Heyes E; Iacob RE; Kessler D; Kölle H; Lamarre L; Lancia DR; Lucas S; Mayer M; Mayr K; Mischerikow N; Mück K; Peinsipp C; Petermann O; Reiser U; Rudolph D; Rumpel K; Salomon C; Scharn D; Schnitzer R; Schrenk A; Schweifer N; Thompson D; Traxler E; Varecka R; Voss T; Weiss-Puxbaum A; Winkler S; Zheng X; Zoephel A; Kraut N; McConnell D; Pearson M; Koegl M
    Cell Rep; 2017 Sep; 20(12):2860-2875. PubMed ID: 28930682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Significance of
    Ting CY; Chang KM; Kuan JW; Sathar J; Chew LP; Wong OJ; Yusuf Y; Wong L; Samsudin AT; Pana MNBM; Lee SK; Gopal NSR; Puri R; Ong TC; Bahari SK; Goh AS; Teoh CS
    Int J Med Sci; 2019; 16(4):556-566. PubMed ID: 31171907
    [No Abstract]   [Full Text] [Related]  

  • 14. GSK137, a potent small-molecule BCL6 inhibitor with in vivo activity, suppresses antibody responses in mice.
    Pearce AC; Bamford MJ; Barber R; Bridges A; Convery MA; Demetriou C; Evans S; Gobbetti T; Hirst DJ; Holmes DS; Hutchinson JP; Jayne S; Lezina L; McCabe MT; Messenger C; Morley J; Musso MC; Scott-Stevens P; Manso AS; Schofield J; Slocombe T; Somers D; Walker AL; Wyce A; Zhang XP; Wagner SD
    J Biol Chem; 2021 Aug; 297(2):100928. PubMed ID: 34274316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms.
    Parekh S; Polo JM; Shaknovich R; Juszczynski P; Lev P; Ranuncolo SM; Yin Y; Klein U; Cattoretti G; Dalla Favera R; Shipp MA; Melnick A
    Blood; 2007 Sep; 110(6):2067-74. PubMed ID: 17545502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Thiourea-Based Inhibitors of the B-Cell Lymphoma 6 BTB Domain via NMR-Based Fragment Screening and Computer-Aided Drug Design.
    Cheng H; Linhares BM; Yu W; Cardenas MG; Ai Y; Jiang W; Winkler A; Cohen S; Melnick A; MacKerell A; Cierpicki T; Xue F
    J Med Chem; 2018 Sep; 61(17):7573-7588. PubMed ID: 29969259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MEF2B is a member of the BCL6 gene transcriptional complex and induces its expression in diffuse large B-cell lymphoma of the germinal center B-cell-like type.
    El Jamal SM; Grada Z; El Dinali MH; Zhou H; Hassan SY; Saad AG; Gibson B; Zhou X; Abulsayen HA; Khadra HS; Friedman J; Shalaby H; Kadi A; Megahed M; Emberesh M; Teruya-Feldstein J; Firpo-Betancourt A; Haikel Y; Fraig M; Hassan M
    Lab Invest; 2019 Apr; 99(4):539-550. PubMed ID: 30446717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCL6 repression of EP300 in human diffuse large B cell lymphoma cells provides a basis for rational combinatorial therapy.
    Cerchietti LC; Hatzi K; Caldas-Lopes E; Yang SN; Figueroa ME; Morin RD; Hirst M; Mendez L; Shaknovich R; Cole PA; Bhalla K; Gascoyne RD; Marra M; Chiosis G; Melnick A
    J Clin Invest; 2010 Dec; 120(12):4569-82. PubMed ID: 21041953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BCL6 as a therapeutic target for lymphoma.
    Leeman-Neill RJ; Bhagat G
    Expert Opin Ther Targets; 2018 Feb; 22(2):143-152. PubMed ID: 29262721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of primary central nervous system large B-cell lymphoma in the era of high-grade B-cell lymphoma: Detection of two cases with MYC and BCL6 rearrangements in a cohort of 12 cases.
    Pina-Oviedo S; Bellamy WT; Gokden M
    Ann Diagn Pathol; 2020 Oct; 48():151610. PubMed ID: 32889391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.